EUVIMEDEUVIMED entdecken
Crossref

Enhancing Sonodynamic Therapy for Cervical Cancer Using Ultrasound-Activated BTO@PEG

Chengqing Liu, Lu Ding, Shangke Chen, Lu Liu, Xiang Zeng, Qi Yan, Jiabo Wang, Nazila Saitiniaz, Nan Yang, Xiaoya Xu, Yuming Mu, Zhen Chen und 1 weitere

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c00765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Chengqing Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Special Environment and Health Research in Xinjiang, School of Public Health, Xinjiang Medical University, 567 Shangde North Road, …. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Polyethylene Glycols, Titanium, Ultrasonic Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Natural Science Foundation of Xinjiang Uygur Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with advanced cervical cancer have a poor prognosis, and sonodynamic therapy (SDT) is expected to offer a new approach for improving the therapeutic outcome of cervical cancer due to its noninvasiveness and ability to penetrate deeply into tissues. In order to overcome the problems of the rapid elimination and low water solubility of organic acoustic sensitizers in SDT, DSPE-PEG2000-coated tetragonal-phase barium titanate nanoparticles (BTO@PEG) were employed in this study to replace the conventional nanoacoustic sensitizers. It was found that BTO@PEG could continuously generate ROS through SDT and the piezoelectric effect under ultrasound (US) stimulation, which subsequently promoted the apoptosis of cervical cancer cells and inhibited the growth of subcutaneously transplanted HeLa-derived cervical cancer tumors in nude mice. BTO@PEG showed good biocompatibility, as confirmed by cytology and animal experiments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPolyethylene GlycolsTitaniumUltrasonic TherapyBarium CompoundsFemaleAnimalsHumansMiceMice, NudeHeLa CellsApoptosisMice, Inbred BALB CNanoparticlesReactive Oxygen SpeciesCell Line, TumorXenograft Model Antitumor Assays

Stichwörter der Autor:innen

acoustic kinetic therapyapoptosiscervical cancerreactive oxygen speciestetragonal-phase barium titanate

Substanzen

Polyethylene GlycolsTitaniumBarium Compoundsbarium titanate(IV)Reactive Oxygen Species

Autor:innen und Institutionen

  • Key Laboratory of Special Environment and Health Research in Xinjiang, School of Public Health, Xinjiang Medical University, 567 Shangde North Road, Urumqi 830017, PR China.
  • Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi 830041, PR China.
  • Xinjiang Key Laboratory of Ultrasound Medicine, 137 Liyushan South Road, Urumqi 830013, PR China.
  • The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China.

ORCID-Profile: Rong Li

Förderung

  • Natural Science Foundation of Xinjiang Uygur Autonomous Region

Zitieren

APA

Liu, C., Ding, L., Chen, S., Liu, L., Zeng, X., Yan, Q., Wang, J., Saitiniaz, N., Yang, N., Xu, X., Mu, Y., Chen, Z., & Li, R. (2025). Enhancing Sonodynamic Therapy for Cervical Cancer Using Ultrasound-Activated BTO@PEG. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00765

Vancouver

Liu C, Ding L, Chen S, Liu L, Zeng X, Yan Q, et al. Enhancing Sonodynamic Therapy for Cervical Cancer Using Ultrasound-Activated BTO@PEG. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00765

BibTeX
@article{Liu2025,
  author = {Liu, Chengqing and Ding, Lu and Chen, Shangke and Liu, Lu and Zeng, Xiang and Yan, Qi and Wang, Jiabo and Saitiniaz, Nazila and Yang, Nan and Xu, Xiaoya and Mu, Yuming and Chen, Zhen and Li, Rong},
  title = {Enhancing Sonodynamic Therapy for Cervical Cancer Using Ultrasound-Activated BTO@PEG},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c00765}
}
Kostenlos starten →